Report : North America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
At 12.8% CAGR, North America Microcarriers Market is Speculated to be Worth US$ 1,933.56 Million by 2030, says Business Market Insights
According to Business Market Insights research, the North America microcarriers market was valued at US$ 736.67 million in 2022 and is expected to reach US$ 1,933.56 million by 2030, registering a CAGR of 12.8% from 2022 to 2030. Need for cell therapies with rising incidence of cancer and infectious diseases and increasing popularity of outsourcing cell and gene therapy manufacturing are among the critical factors attributed to the North America microcarriers market expansion.
World Health Organization (WHO) states that the global burden of cancer is estimated to rise to 27.5 million new cases and 16.3 million mortalities by 2040. The American Cancer Society projected 1,918,030 new cancer cases and 609,360 cancer deaths in the US for the year 2022, including nearly 350 deaths/day from lung cancer, which is a major cause of cancer mortality. According to World Health Organization (WHO) tuberculosis (TB) is the 13th top cause of death globally and the second leading infectious disease after COVID-19. According to the WHO, there were 1.5 million deaths caused by TB in 2020 (including 214,000 people affected by HIV). In 2020, WHO projected that 10 million people had TB globally, including 1.1 million children, 3.3 million women, and 5.6 million men. TB is present in all age groups and countries. Furthermore, infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), ~ 37.7 million people had HIV in 2020 globally. Out of these, 1.7 million were children aged 0-14 years, and 36 million were adults. Also, more than half (53%) were girls and women. 1.5 million new HIV cases were reported in 2020 globally. Similarly, hepatitis is inflammation of the liver caused by a viral infection. The five main strains of hepatitis viruses are A, B, C, D, and E. According to World Health Organization (WHO), around 58 million people across the globe have chronic hepatitis C virus infection, and ~1.5 million new infections occur every year. The increasing incidence of diseases where cell therapy can be effectively applied, such as cancers, urinary problems, autoimmune diseases, and infectious diseases, is associated with the growth of the microcarriers market. Microcarriers are tiny spheres or particles (typically 90-300 µm in diameter) used for culturing adherent cells in stirred-tank bioreactors. With the growing incidence of cancer and various infectious diseases, the need for proper medication and vaccines arises, which favors the microcarriers market growth.
On the contrary, high cost of biologics and cell-based therapies hampers the North America microcarriers market.
Based on product, the North America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 69.6% share of North America microcarriers market in 2022, amassing US$ 513.02 million. It is projected to garner US$ 1,369.85 million by 2030 to expand at 13.1% CAGR during 2022-2030.
In terms of equipment, the North America microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 64.6% share of North America microcarriers market in 2022, amassing US$ 476.17 million. It is projected to garner US$ 1,274.40 million by 2030 to expand at 13.1% CAGR during 2022-2030.
Based on application, the North America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 50.7% share of North America microcarriers market in 2022, amassing US$ 373.42 million. It is projected to garner US$ 1,018.83 million by 2030 to expand at 13.4% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.1% share of North America microcarriers market in 2022, amassing US$ 405.83 million. It is projected to garner US$ 1,091.36 million by 2030 to expand at 13.2% CAGR during 2022-2030.
By country, the North America microcarriers market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.1% share of North America microcarriers market in 2022. It was assessed at US$ 612.22 million in 2022 and is likely to hit US$ 1,633.04 million by 2030, exhibiting a CAGR of 13.0% during 2022-2030.
Key players operating in the North America microcarriers market are Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc, among others.
- In June 2023, Teijin Ltd introduced the new nonwoven microcarriers for speedy and large-scale cell culture. This scaffolding substance promotes three-dimensional adhesion and growth for a variety of cell types.
- In May 2022, The company released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com